K202955 is an FDA 510(k) clearance for the Contour Light CL-100. Classified as Fat Reducing Low Level Laser within the OLI classification (a category for non-invasive low-level laser body contouring systems), Class II - Special Controls.
Submitted by Contour Research, LLC (Reno, US). The FDA issued a Cleared decision on May 19, 2021 after a review of 231 days - an extended review cycle.
This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.5400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.
View all Contour Research, LLC devices
NCT04451824
Completed
Interventional
Industry-sponsored
Examination of Circumferential Reduction
Contour Research CL-100 Examination of Circumferential Reduction: A Review of Data Collected From Routine Use of the Device
| Condition studied |
Overweight or Obesity |
| Study design |
Single group |
| Eligibility |
All sexes
· 18 Years+
· Healthy volunteers accepted
|
| Principal investigator |
Doug Dreier, BS |
| Sponsor |
Contour Research
(industry)
|
Started 2018-09-01
→
Primary completion 2018-11-30
→
Completed 2018-12-31
Primary outcome
Examination of Circumferential Reduction - Primary Objective
Secondary outcome
Examination of Circumferential Reduction - Secondary Objective
Study completed - no results published.
This trial concluded in 2018 but has not posted
results to ClinicalTrials.gov. Completed studies without public results are common
in industry-sponsored device trials; the data may be referenced in the
510(k) Summary PDF or remain unpublished.
Individual participant data will not be shared.
View full study on ClinicalTrials.gov